Regulatory Expert Weighs Impact of the LDT Final Rule

Manufacturers of laboratory-developed tests (LDT) are concerned that the FDA will lack the resources to deal with a flood of premarket approval applications as the agency implements its recent final rule asserting oversight of LDTs as medical devices.
Source: Drug Industry Daily